ACAD
41.69
+0.02
+0.05%
AEMD
6.9
-0.1
-1.43%
APRI
1.85
+0.17
+10.12%
ARNA
4.44
-0.03
-0.67%
ATEC
1.39
+0.01
+0.72%
CNAT
5.16
-0.08
-1.53%
CRXM
0.327
-0.033
-9.2778%
CYTX
0.548
-0.003
-0.5449%
DXCM
79.36
-0.41
-0.51%
GNMK
8.91
+0.16
+1.83%
HALO
22.1
-0.4
-1.78%
ILMN
220.07
-0.61
-0.28%
INNV
0.12
0.00
0.00%
INO
7.92
-0.22
-2.70%
ISCO
0.043
-0.004
-7.527%
ISIS
56.13
-1.03
-1.80%
LGND
98.6
+1.51
+1.56%
LPTN
0.275
-0.005
-1.6446%
MBVX
2.71
+0.19
+7.54%
MEIP
1.77
+0.07
+4.12%
MNOV
4.02
+0.09
+2.29%
MRTX
31.3
-0.39
-1.23%
MSTX
0.48
-0.01
-2.04%
NBIX
47.31
-0.35
-0.73%
NUVA
47.29
-0.23
-0.48%
ONCS
6.35
-0.25
-3.79%
ONVO
3.74
+0.03
+0.81%
OREX
4.76
-0.17
-3.45%
OTIC
22.09
-0.52
-2.30%
QDEL
23.01
+0.04
+0.17%
RCPT
194.91
-1.36
-0.69%
RGLS
10.2
-0.34
-3.23%
RMD
55.31
+0.01
+0.02%
SCIE
0.016
0.00
0.00%
SPHS
0.823
+0.04
+5.149%
SRNE
16.68
-0.53
-3.08%
TROV
9.53
-0.19
-1.95%
VICL
0.7
+0.015
+2.1752%
ZGNX
12.8
-1.16
-8.31%
ACAD
41.69
+0.02
+0.05%
AEMD
6.9
-0.1
-1.43%
APRI
1.85
+0.17
+10.12%
ARNA
4.44
-0.03
-0.67%
ATEC
1.39
+0.01
+0.72%
CNAT
5.16
-0.08
-1.53%
CRXM
0.327
-0.033
-9.2778%
CYTX
0.548
-0.003
-0.5449%
DXCM
79.36
-0.41
-0.51%
GNMK
8.91
+0.16
+1.83%
HALO
22.1
-0.4
-1.78%
ILMN
220.07
-0.61
-0.28%
INNV
0.12
0.00
0.00%
INO
7.92
-0.22
-2.70%
ISCO
0.043
-0.004
-7.527%
ISIS
56.13
-1.03
-1.80%
LGND
98.6
+1.51
+1.56%
LPTN
0.275
-0.005
-1.6446%
MBVX
2.71
+0.19
+7.54%
MEIP
1.77
+0.07
+4.12%
MNOV
4.02
+0.09
+2.29%
MRTX
31.3
-0.39
-1.23%
MSTX
0.48
-0.01
-2.04%
NBIX
47.31
-0.35
-0.73%
NUVA
47.29
-0.23
-0.48%
ONCS
6.35
-0.25
-3.79%
ONVO
3.74
+0.03
+0.81%
OREX
4.76
-0.17
-3.45%
OTIC
22.09
-0.52
-2.30%
QDEL
23.01
+0.04
+0.17%
RCPT
194.91
-1.36
-0.69%
RGLS
10.2
-0.34
-3.23%
RMD
55.31
+0.01
+0.02%
SCIE
0.016
0.00
0.00%
SPHS
0.823
+0.04
+5.149%
SRNE
16.68
-0.53
-3.08%
TROV
9.53
-0.19
-1.95%
VICL
0.7
+0.015
+2.1752%
ZGNX
12.8
-1.16
-8.31%
Home » Archive by Category

Xconomy

West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More

April 10, 2015 – 12:56 pm

We’ll move in geographic fashion through the roundup this week, starting in the Pacific Northwest, where Juno Therapeutics won a patent fight and found a new headquarters. Further south, the…

[[Click headline to continue reading.]]

Tax Time Alert: Key Things to Know About Founders Preferred Stock

April 10, 2015 – 6:11 am

As you gather and review tax papers for your return, be sure to inform your accountant if you hold founders’ preferred stock, or if you sold a block of it in 2014. Your CPA might not think to ask you…

[[Click headline to continue reading.]]

Tax Time Alert: Key Things to Know About Founders Preferred Stock

April 10, 2015 – 6:11 am

As you gather and review tax papers for your return, be sure to inform your accountant if you hold founders’ preferred stock, or if you sold a block of it in 2014. Your CPA might not think to ask you…

[[Click headline to continue reading.]]

Tax Time Alert: Key Things to Know About Founders Preferred Stock

April 10, 2015 – 6:11 am

As you gather and review tax papers for your return, be sure to inform your accountant if you hold founders’ preferred stock, or if you sold a block of it in 2014. Your CPA might not think to ask you…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]